Table 1.

Prognostic factors associated with oncologic outcome after resection of pancreatic cancer recurrence according to retrospective studies

Clinical parameters associated with prognostic benefit	Molecular markers associated with prognostic benefit
Patient age, <65 years [33]	IPMN-associated primary carcinoma [37]
Preoperative chemotherapy [33]	KRAS-wild-type tumor [42]
Completion of adjuvant chemotherapy [34]	SMAD4-wild-type tumor [45]
Time from initial resection, >10 months [34]
Low CA 19–9 level [30]
BMI > 20 kg/m2 [33]
R0 resection of tumor recurrence [30]
Recurrence in the remnant pancreas or in the lung [34]